Is AI used in IVF clinics today?

Yes — increasingly common across major clinics in 2026. The most widespread applications are: time-lapse embryo monitoring with AI scoring (KIDScore, iDAScore, Life Whisperer, Embryoscope+ algorithms); AI-assisted sperm analysis (CASA systems); AI-supported follicle counting on ultrasound; and patient-facing AI navigators that help with cycle organisation and questions. Less mature: AI for stimulation protocol selection, AI prediction of OHSS risk. Hyped beyond evidence: most claims of dramatic success rate improvements purely from AI.

What is AI embryo selection?

Time-lapse incubators (Embryoscope, Geri, Miri) photograph embryos every 5–10 minutes during development. AI algorithms (KIDScore, iDAScore, Life Whisperer, ERICA) analyse millions of embryo images to predict implantation potential. The output is typically a score for each embryo, ranking which should be transferred first. AI does not replace embryologist judgment — it supplements it. Strongest evidence is for ranking embryos within a cohort, not for absolute viability prediction.

Does AI embryo selection improve IVF success rates?

Modestly, in some studies — but the picture is mixed. AI ranking helps select the best embryo from a cohort to transfer first, which improves time-to-pregnancy. It does not increase the cumulative live birth rate per egg retrieval (the underlying biology is unchanged). For patients with multiple high-quality embryos, AI ranking saves time across cycles. For patients with one or two embryos, the benefit is smaller. Marketing claims of 25%+ success rate improvements purely from AI are not supported by independent peer-reviewed evidence.

Should I choose a clinic based on whether they use AI?

Not as a primary criterion. AI embryo selection is one of many quality signals — and even the best AI cannot rescue a poorly run lab or weak clinical protocol. Better signals: lab KPIs (fertilisation, blastulation rates), live birth rate per embryo transferred for your age, embryologist experience, and how the clinic handles non-AI decisions (freeze-all thresholds, ICSI selection, transfer policy). AI presence is reasonable to ask about; AI absence is not necessarily a red flag at a strong clinic.

How is AI used for patients (not just clinicians)?

AI patient navigators help with cycle organisation, plain-language explanation of test results, medication reminders, and answering common questions between appointments. Nestie's chat at chat.nestie.co is one example of a patient-side AI navigator — others include built-in clinic apps and several telehealth fertility platforms. The strength of patient-side AI is reducing anxiety and information asymmetry; the weakness is that AI cannot replace clinical judgment for treatment decisions.

Will AI replace embryologists or REs?

No, and the question slightly misses the point. AI augments embryologists by handling pattern recognition tasks (ranking embryos, scoring sperm, counting follicles) at scale and consistency. It does not replace clinical judgment, communication with patients, or decisions that involve trade-offs. Reproductive endocrinologists make decisions involving ethics, patient preferences, and uncertainty that AI is not equipped to handle. The likely 2030 picture is human clinicians supported by AI, not AI replacing them.

What about AI sperm analysis?

Computer-Aided Sperm Analysis (CASA) systems have been around for decades and are now increasingly AI-driven. AI improves accuracy and consistency of sperm count, motility, and morphology assessment versus manual microscopy. AI sperm DNA fragmentation analysis is emerging. Quality varies by vendor — ASRM-validated systems are the most reliable. CASA is widespread in 2026 and has largely replaced manual analysis at high-volume andrology labs.

AI in IVF 2026: Embryo Selection, Patient Navigation, What's Real and What's Hype

AI is now part of routine IVF practice — but the public conversation oscillates between over-claiming (dramatic success rate improvements purely from AI) and under-claiming (dismissal as marketing). The reality is more useful and more boring: AI is meaningfully improving specific tasks (embryo ranking, sperm analysis, patient navigation), and is unlikely to transform the underlying biology of fertility.

This guide walks through where AI is actually used in IVF in 2026, what the evidence supports, and how patients should weigh AI presence at clinics. The aim is to give you the right questions to ask — not to take a side in the hype debate.

What does AI actually do in IVF?

Three main applications. Embryo selection: AI scores time-lapse images of embryos to rank which to transfer first (KIDScore, iDAScore, Life Whisperer, Embryoscope+ algorithms). Sperm analysis: AI-driven CASA systems improve accuracy of count, motility, morphology versus manual microscopy. Patient navigation: AI chatbots help organise cycles, explain results, and answer questions between appointments. Less mature applications include AI stimulation protocol selection and AI OHSS risk prediction.

Is AI in IVF safe and regulated?

AI tools used in IVF labs are increasingly regulated as medical devices in major markets (FDA in the US, MDR in EU, MHRA in UK). Embryo selection AI requires clinical validation studies for regulatory approval. Patient-facing AI tools (like AI navigators) are typically classified as wellness or information tools rather than medical devices, with lighter oversight. As a patient, asking what AI tools your clinic uses and whether they have regulatory clearance is reasonable.

What AI Actually Does — By Application

Application	Maturity in 2026	Evidence strength
Embryo time-lapse + AI scoring	Mainstream	Moderate (helps ranking, not biology)
CASA sperm analysis	Mainstream	Strong (vs manual microscopy)
AI follicle counting on US	Growing	Moderate
AI patient navigators	Mainstream consumer	Strong for usability; clinical evidence emerging
AI stimulation protocol	Pilot stage	Weak (too few trials)
AI OHSS prediction	Pilot stage	Weak
AI sperm DNA fragmentation	Emerging	Weak

AI Embryo Selection in Detail

Time-lapse incubators photograph each embryo every 5–10 minutes from fertilisation through day 5–6 (blastocyst). AI algorithms analyse the resulting video alongside large training datasets of known outcomes (transferred → live birth or not).

Common platforms

• KIDScore (Vitrolife / Embryoscope) — long-established, used widely
• iDAScore (Vitrolife) — newer deep-learning model
• Life Whisperer — AI from static images, integrates with multiple incubators
• Embryoscope+ algorithm — clinic-customisable
• ERICA — embryo ranking platform
• Various clinic-built models — large clinic networks increasingly train their own

What AI embryo selection does well

• Ranks embryos within a cohort consistently (less embryologist variance)
• Can identify subtle morphokinetic patterns invisible to humans
• Improves time-to-pregnancy by selecting best first transfer
• Provides documentation trail for transfer decisions

What AI embryo selection does NOT do

• Increase the number of viable embryos in your cohort
• Replace PGT-A for chromosomal screening
• Predict whether ANY individual embryo will succeed (only relative ranking)
• Improve cumulative live birth rate per egg retrieval (the biology is unchanged)

Your IVF journey, organised and free

IVFPath is built for IVF patients — track medications, appointments, lab results, and costs all in one place.

💊

Medication Reminders

Never miss a dose — log every injection and tablet

📅

Appointment Calendar

All your scans, retrievals and transfers in one view

💰

Cost Tracker

Track spending so nothing is a surprise

Start for free — no card needed

Free · No credit card · Works on any device

AI Sperm Analysis

Computer-Aided Sperm Analysis (CASA) systems have largely replaced manual microscopy at high-volume labs in 2026. AI improvements include:

Higher accuracy and consistency on count, motility, and morphology
Reduced inter-observer variability
Automated workflow reduces analysis time
Emerging applications: AI sperm DNA fragmentation, AI sperm selection for ICSI

For patients, the practical implication: ask whether your clinic uses CASA or manual analysis, and whether their morphology assessment is using strict (Kruger) criteria. Both affect comparability of your results.

Patient-Facing AI Navigators

The fastest-growing AI application in fertility is patient-side. AI navigators help with:

Plain-language explanation of test results (estradiol, progesterone, beta hCG, AMH)
Cycle organisation and medication reminders
Answering questions between appointments without waiting on clinic staff
Drafting questions to bring to consultations
Comparing protocols or clinic recommendations
Multilingual support for cross-border or diaspora patients

A note on what AI navigators cannot do

AI navigators are information and orientation tools, not clinical decision-makers. They reduce information asymmetry between patients and clinicians, which is a meaningful outcome — but they do not diagnose, prescribe, or replace your reproductive endocrinologist. Use them for understanding and preparation; rely on your clinical team for treatment decisions.

Where the Marketing Runs Ahead

"AI improves IVF success rates by 25%+" — Independent meta-analyses do not show this magnitude. Marketing is comparing best AI vs worst manual, not real-world impact
"Our AI predicts which embryo will become a baby" — AI ranks embryos but cannot predict viability with high accuracy at the individual level
"AI eliminates embryologist subjectivity" — AI training data comes from embryologist judgment; it inherits some of the same variation
"Soon AI will replace IVF as we know it" — The biological constraints (egg quality decline with age, sperm DNA damage, uterine receptivity) are not AI-solvable
"Every clinic with AI is better than every clinic without" — Lab quality, embryologist skill, and protocol matter more than AI presence

What to Ask Your Clinic

Do you use time-lapse imaging? If yes, which platform?
Do you use AI embryo selection? Which model?
How does the AI score factor into your transfer decisions vs embryologist judgment?
What evidence have you seen for outcome improvement with the AI you use?
Is your AI tool regulated as a medical device in your country?
For sperm analysis: do you use CASA or manual?

Want help comparing clinics on AI use?

AI in IVF is a moving target — new platforms emerge yearly. Nestie's AI assistant can help you ask the right questions about a specific clinic's technology stack and interpret what the answers mean for your decision.

Compare clinics with Nestie →

What Is Plausibly Coming

AI-personalised stimulation protocols based on AMH, AFC, and prior cycle response
Real-time AI OHSS risk prediction with protocol adjustment recommendations
Multi-modal AI integrating imaging, hormone trajectories, genetics, and embryology
Generative AI for patient communication, document generation, and education at scale
Cross-border AI navigators handling regulatory and logistical complexity

What is unlikely in the near term: AI bypassing the underlying biology. Egg quality trajectories with age, sperm DNA damage repair, uterine receptivity windows — these are biological constraints that AI organises information around but does not change.

Frequently Asked Questions

References

Information drawn from peer-reviewed publications on AI embryo selection (KIDScore, iDAScore, Life Whisperer, ERICA validation studies), ESHRE position statements on AI in ART, ASRM technical bulletins, and FDA / MHRA / MDR regulatory guidance for AI medical devices. AI in IVF is evolving fast — verify current tools and evidence with your specific clinic.

AI in IVF 2026: What's Real, What's Hype, What to Ask